- Home
- HUMAW vs PRMB Comparison
HUMAW vs PRMB Comparison
Compare HUMAW & PRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- PRMB
- Stock Information
- Founded
- HUMAW 2004
- PRMB 1955
- Country
- HUMAW United States
- PRMB United States
- Employees
- HUMAW 185
- PRMB N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- PRMB
- Sector
- HUMAW Health Care
- PRMB
- Exchange
- HUMAW Nasdaq
- PRMB Nasdaq
- Market Cap
- HUMAW N/A
- PRMB N/A
- IPO Year
- HUMAW N/A
- PRMB N/A
- Fundamental
- Price
- HUMAW $0.34
- PRMB $33.18
- Analyst Decision
- HUMAW
- PRMB Strong Buy
- Analyst Count
- HUMAW 0
- PRMB 6
- Target Price
- HUMAW N/A
- PRMB $41.50
- AVG Volume (30 Days)
- HUMAW 14.2K
- PRMB 4.6M
- Earning Date
- HUMAW 03-21-2025
- PRMB 05-08-2025
- Dividend Yield
- HUMAW N/A
- PRMB 3.62%
- EPS Growth
- HUMAW N/A
- PRMB N/A
- EPS
- HUMAW N/A
- PRMB N/A
- Revenue
- HUMAW N/A
- PRMB $5,152,500,000.00
- Revenue This Year
- HUMAW N/A
- PRMB $39.35
- Revenue Next Year
- HUMAW N/A
- PRMB $4.19
- P/E Ratio
- HUMAW N/A
- PRMB N/A
- Revenue Growth
- HUMAW N/A
- PRMB 9.66
- 52 Week Low
- HUMAW $1.18
- PRMB $18.40
- 52 Week High
- HUMAW $1.34
- PRMB $35.85
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- PRMB N/A
- Support Level
- HUMAW N/A
- PRMB N/A
- Resistance Level
- HUMAW N/A
- PRMB N/A
- Average True Range (ATR)
- HUMAW 0.00
- PRMB 0.00
- MACD
- HUMAW 0.00
- PRMB 0.00
- Stochastic Oscillator
- HUMAW 0.00
- PRMB 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.